Gilead Sciences
GILD
#92
Rank
C$250.54 B
Marketcap
C$201.82
Share price
1.32%
Change (1 day)
21.03%
Change (1 year)

Market capitalization of Gilead Sciences (GILD)

Market cap: C$250.54 Billion

As of March 2026 Gilead Sciences has a market cap of C$250.54 Billion. This makes Gilead Sciences the world's 92th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Gilead Sciences from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026C$250.54 B18.24%
2025C$211.89 B25.9%
2024C$168.30 B25.71%
2023C$133.88 B-8.37%
2022C$146.11 B25.91%
2021C$116.04 B24.62%
2020C$93.11 B-13.33%
2019C$107.44 B-1.64%
2018C$109.23 B-7.16%
2017C$117.65 B-7.2%
2016C$126.78 B-36.48%
2015C$199.60 B21.73%
2014C$163.97 B33.67%
2013C$122.66 B121.11%
2012C$55.47 B77.4%
2011C$31.27 B7.64%
2010C$29.05 B-29.08%
2009C$40.96 B-27.65%
2008C$56.61 B32.79%
2007C$42.63 B22.3%
2006C$34.85 B23.89%
2005C$28.13 B49.17%
2004C$18.86 B17%
2003C$16.12 B51.94%
2002C$10.61 B5%
2001C$10.10 B72.49%
2000C$5.85 B70.19%
1999C$3.44 B77.54%
1998C$1.93 B18.07%
1997C$1.64 B66.75%
1996C$0.98 B

End of Day market cap according to different sources

On Mar 10th, 2026 the market cap of Gilead Sciences was reported to be:

C$250.54 Billion
by Nasdaq info icon info icon
C$250.54 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$797.86 B 218.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$209.80 B-16.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$545.29 B 117.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.217 T 385.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$274.93 B 9.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$37.56 B-85.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$25.41 B-89.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$172.26 B-31.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$393.27 B 56.97%๐Ÿ‡บ๐Ÿ‡ธ USA